Clinical Trial Update: Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the efficacy and safety of adding Bevacizumab to the FOLFIRINOX regimen in patients with colorectal cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFIRINOX regimen (folinic acid, fluorouracil, irinotecan, oxaliplatin) (FOLFIRINOX)

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING